Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 34
Filter
1.
Pediatr Infect Dis J ; 36(5): 504-506, 2017 May.
Article in English | MEDLINE | ID: mdl-28403054

ABSTRACT

A prospective cohort study of children with primary immunodeficiencies undergoing hematopoietic stem cell transplant in the United Kingdom investigated the extent and significance of Cryptosporidium carriage in this high risk group. Three of 42 children recruited were infected with Cryptosporidium, a lower proportion than previously described. One had serious disease. The underlying immunodeficiency likely had a bearing on the clinical presentation and possible outcome of infection.


Subject(s)
Cryptosporidiosis/epidemiology , Cryptosporidium/isolation & purification , Hematopoietic Stem Cell Transplantation , Immunologic Deficiency Syndromes/epidemiology , Child , Child, Preschool , Cryptosporidiosis/immunology , Cryptosporidiosis/parasitology , Cryptosporidiosis/therapy , Cryptosporidium/growth & development , Europe/epidemiology , Female , Humans , Immunologic Deficiency Syndromes/immunology , Immunologic Deficiency Syndromes/parasitology , Immunologic Deficiency Syndromes/therapy , Infant , Male , Prevalence , Prospective Studies
2.
Rev Med Interne ; 38(5): 337-339, 2017 May.
Article in French | MEDLINE | ID: mdl-28347510

ABSTRACT

INTRODUCTION: Good syndrome is a rare condition in which thymoma is associated with hypogammaglobulinemia. It is characterized by an increased susceptibility to infections. CASE REPORT: We report a woman with Good's syndrome diagnosed after severe congenital toxoplasmosis in her daughter, even though she was immunized against this infection during pregnancy. CONCLUSION: This presentation is very unusual by its early diagnosis and to our knowledge is the first report of parasitic infection in this syndrome.


Subject(s)
Immunologic Deficiency Syndromes/complications , Pregnancy Complications, Parasitic/etiology , Thymoma/complications , Thymus Neoplasms/complications , Toxoplasma/physiology , Toxoplasmosis, Congenital/etiology , Toxoplasmosis/transmission , Adult , Female , Humans , Immunologic Deficiency Syndromes/parasitology , Infant, Newborn , Pregnancy , Pregnancy Complications, Parasitic/immunology , Rare Diseases , Severity of Illness Index , Thymoma/immunology , Thymoma/parasitology , Thymus Neoplasms/immunology , Thymus Neoplasms/parasitology , Toxoplasma/immunology , Toxoplasmosis/complications , Toxoplasmosis/immunology , Toxoplasmosis, Congenital/immunology , Vaccination
3.
J Exp Med ; 213(7): 1307-18, 2016 06 27.
Article in English | MEDLINE | ID: mdl-27270894

ABSTRACT

Human babesiosis is a tick-borne multisystem disease caused by Babesia species of the apicomplexan phylum. Most clinical cases and fatalities of babesiosis are caused by Babesia microti Current treatment for human babesiosis consists of two drug combinations, atovaquone + azithromycin or quinine + clindamycin. These treatments are associated with adverse side effects and a significant rate of drug failure. Here, we provide evidence for radical cure of experimental babesiosis in immunodeficient mice using a combination of an endochin-like quinolone (ELQ) prodrug and atovaquone. In vivo efficacy studies in mice using ELQ-271, ELQ-316, and the ELQ-316 prodrug, ELQ-334, demonstrated excellent growth inhibitory activity against the parasite, with potency equal to that of orally administered atovaquone at 10 mg/kg. Analysis of recrudescent parasites after ELQ or atovaquone monotherapy identified genetic substitutions in the Qi or Qo sites, respectively, of the cytochrome bc1 complex. Impressively, a combination of ELQ-334 and atovaquone, at doses as low as 5.0 mg/kg each, resulted in complete clearance of the parasite with no recrudescence up to 122 d after discontinuation of therapy. These results will set the stage for future clinical evaluation of ELQ and atovaquone combination therapy for treatment of human babesiosis.


Subject(s)
Atovaquone/pharmacology , Babesia microti/immunology , Babesiosis/drug therapy , Immunologic Deficiency Syndromes/parasitology , Prodrugs/pharmacology , Quinolones/pharmacology , Animals , Babesiosis/genetics , Babesiosis/immunology , Immunologic Deficiency Syndromes/genetics , Immunologic Deficiency Syndromes/immunology , Mice , Mice, SCID
4.
Eur J Immunol ; 32(3): 858-67, 2002 03.
Article in English | MEDLINE | ID: mdl-11870630

ABSTRACT

In humans infected with lymphatic filariasis, microfilaraemia [the presence of microfilariae (Mf) in the blood] is generally associated with both poor antigen (Ag)-specific proliferative responses and with protection from severe disease. Clonal deletion has been suggested as one possible mechanism by which parasite-reactive lymphocytes, that may be capable of mediating resistance and/or immunopathology, are silenced in asymptomatic carriers. In this study we demonstrate that splenic lymphocytes from mice infected with microfilariae of Brugia pahangi display an Ag-specific proliferative defect. However, these cells were not completely unresponsive since they produced high levels of Ag-specific IFN-gamma. Using TdT-mediated dUTP-biotin nick end labeling for flow cytometry, CD4(+) lymphocytes from Mf-infected mice cultured with Ag showed high levels of apoptosis when compared to those from L3-infected mice which proliferated well in response to Ag. Treatment of Ag-stimulated cultures with aminoguanidine (AMG), an inhibitor of inducible nitric oxide synthase, rescued the CD4(+) T cells from apoptosis and reversed the proliferative defect. Furthermore, carboxyfluorescein diacetate succinimidyl ester labeling allowed the visualization of dividing CD4(+) T cells in cultures from Mf-infected animals only in the presence of AMG. We hypothesize that CD4(+) T cells indirectly trigger their own apoptosis by secreting significant quantities of IFN-gamma resulting in the induction of high levels of nitric oxide, and the subsequent elimination of effector T cells. Our findings are the first direct evidence that infection with Brugia Mf can selectively induce lymphocyte apoptosis, a phenomenon that could contribute to the proliferative defect and parasite persistence associated with the microfilaraemic state in the infected human.


Subject(s)
Apoptosis , Brugia pahangi/physiology , CD4-Positive T-Lymphocytes/pathology , Filariasis/immunology , Microfilariae/physiology , Aedes/parasitology , Animals , Antigens, Helminth/immunology , Brugia pahangi/growth & development , CD4-Positive T-Lymphocytes/enzymology , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/metabolism , Cells, Cultured/drug effects , Enzyme Inhibitors/pharmacology , Filariasis/pathology , Flow Cytometry , Fluoresceins/analysis , Fluorescent Dyes/analysis , Gerbillinae , Guanidines/pharmacology , Immunologic Deficiency Syndromes/etiology , Immunologic Deficiency Syndromes/parasitology , Interferon-gamma/biosynthesis , Mice , Mice, Inbred BALB C , Nitric Oxide/physiology , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase/physiology , Nitric Oxide Synthase Type II , Parasitemia/immunology , Parasitemia/pathology , Spleen/pathology , Succinimides/analysis , Th2 Cells/immunology , Th2 Cells/metabolism
5.
J Immunol ; 165(2): 969-77, 2000 Jul 15.
Article in English | MEDLINE | ID: mdl-10878373

ABSTRACT

A model of Leishmania major infection in C57BL/6 mice has been established that combines two main features of natural transmission: low dose (100 metacyclic promastigotes) and inoculation into a dermal site (the ear dermis). The evolution of the dermal lesion could be dissociated into two distinct phases. The initial "silent" phase, lasting 4-5 wk, favored establishment of the peak load of parasites in the dermis in the absence of lesion formation or any overt histopathologic changes in the site. The second phase corresponds to the development of a lesion associated with an acute infiltration of neutrophils, macrophages, and eosinophils into the dermis and was coincident with the killing of parasites in the site. The onset of immunity/pathology was correlated with the appearance of cells staining for IL-12p40 and IFN-gamma in the epidermal compartment, and an expansion of T cells capable of producing IFN-gamma in the draining lymph node. Parasite growth was not enhanced over the first 4.5 wk in anti-CD4-treated mice, SCID mice, or C57BL/6 mice deficient in IL-12p40, IFN-gamma, CD40 ligand, or inducible NO synthase. These mice all failed to ultimately control infection in the site, but in some cases (anti-CD4 treated, IL-12p40-/-, CD40 ligand-/-, and SCID) high dermal parasite loads were associated with little or no pathology. These results extend to a natural infection model a role for Th1 cells in both acquired resistance and lesion formation, and document the remarkable avoidance of this response during a prolonged phase of parasite amplification in the skin.


Subject(s)
Leishmania major/growth & development , Leishmania major/immunology , Leishmaniasis, Cutaneous/immunology , Leishmaniasis, Cutaneous/parasitology , Skin/immunology , Skin/parasitology , Animals , Cells, Cultured , Cytokines/biosynthesis , Ear, External , Epidermis/immunology , Epidermis/metabolism , Epidermis/parasitology , Epidermis/pathology , Immunity, Innate , Immunologic Deficiency Syndromes/immunology , Immunologic Deficiency Syndromes/parasitology , Immunologic Deficiency Syndromes/pathology , Leishmania major/pathogenicity , Leishmaniasis, Cutaneous/pathology , Leishmaniasis, Cutaneous/transmission , Lymph Nodes/immunology , Lymph Nodes/metabolism , Lymph Nodes/parasitology , Lymph Nodes/pathology , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, SCID , Time Factors
6.
Wiad Parazytol ; 46(3): 335-44, 2000.
Article in Polish | MEDLINE | ID: mdl-16883688

ABSTRACT

The congenital or acquired cause the state of immune deficiency. To acquired factors belong immunosuppressive therapy after grafting and in systemic diseases as infections with HIV. There is a number of parasitic organisms, mainly protozoa, which preferentially settle in immunocompromised persons. The opportunistic parasites are present in the nearest environment. Some of them were newly recognized as human invaders. The state of immune deficiency may reactivate latent infections, that occurs with Toxoplasma gondii infection. Some parasitic infections which are benign and self- resolving, when affecting immunocompetent hosts, become fulminant or disseminated and very often life - threatening in immunosuppressed individuals.


Subject(s)
Immunologic Deficiency Syndromes/epidemiology , Immunologic Deficiency Syndromes/parasitology , Opportunistic Infections/epidemiology , Opportunistic Infections/parasitology , Parasitic Diseases/epidemiology , Parasitic Diseases/parasitology , AIDS-Related Opportunistic Infections/epidemiology , AIDS-Related Opportunistic Infections/parasitology , AIDS-Related Opportunistic Infections/prevention & control , Animals , Candidiasis/epidemiology , Candidiasis/parasitology , Candidiasis/prevention & control , Causality , Comorbidity , Cryptococcosis/epidemiology , Cryptococcosis/parasitology , Cryptococcosis/prevention & control , Cytomegalovirus Infections/epidemiology , Cytomegalovirus Infections/parasitology , Cytomegalovirus Infections/prevention & control , Humans , Immunocompromised Host/immunology , Immunologic Deficiency Syndromes/immunology , Microsporidiosis/epidemiology , Microsporidiosis/parasitology , Microsporidiosis/prevention & control , Opportunistic Infections/prevention & control , Parasitic Diseases/prevention & control , Pneumonia, Pneumocystis/epidemiology , Pneumonia, Pneumocystis/parasitology , Pneumonia, Pneumocystis/prevention & control , Protozoan Infections/epidemiology , Protozoan Infections/parasitology , Protozoan Infections/prevention & control
7.
Infect Immun ; 68(1): 170-5, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10603384

ABSTRACT

We have studied immune mechanisms responsible for control of acute Giardia lamblia and Giardia muris infections in adult mice. Association of chronic G. lamblia infection with hypogammaglobulinemia and experimental infections of mice with G. muris have led to the hypothesis that antibodies are required to control these infections. We directly tested this hypothesis by infecting B-cell-deficient mice with either G. lamblia or G. muris. Both wild-type mice and B-cell-deficient mice eliminated the vast majority of parasites between 1 and 2 weeks postinfection with G. lamblia. G. muris was also eliminated in both wild-type and B-cell-deficient mice. In contrast, T-cell-deficient and scid mice failed to control G. lamblia infections, as has been shown previously for G. muris. Treatment of wild-type or B-cell-deficient mice with antibodies to CD4 also prevented elimination of G. lamblia, confirming a role for T cells in controlling infections. By infecting mice deficient in either alphabeta- or gammadelta-T-cell receptor (TCR)-expressing T cells, we show that the alphabeta-TCR-expressing T cells are required to control parasites but that the gammadelta-TCR-expressing T cells are not. Finally, infections in mice deficient in production of gamma interferon or interleukin 4 (IL-4) and mice deficient in responding to IL-4 and IL-13 revealed that neither the Th1 nor the Th2 subset is absolutely required for protection from G. lamblia. We conclude that a T-cell-dependent mechanism is essential for controlling acute Giardia infections and that this mechanism is independent of antibody and B cells.


Subject(s)
Giardia lamblia/immunology , Giardiasis/immunology , T-Lymphocytes/immunology , Acute Disease , Animals , Antibodies/administration & dosage , B-Lymphocytes/immunology , CD4 Antigens/immunology , Giardia lamblia/isolation & purification , Giardiasis/parasitology , Immunologic Deficiency Syndromes/genetics , Immunologic Deficiency Syndromes/immunology , Immunologic Deficiency Syndromes/parasitology , Interferon-gamma/deficiency , Interferon-gamma/genetics , Interleukin-13/pharmacology , Interleukin-4/deficiency , Interleukin-4/genetics , Interleukin-4/pharmacology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Knockout , Mice, SCID , Receptors, Antigen, T-Cell, alpha-beta/deficiency , Receptors, Antigen, T-Cell, alpha-beta/genetics , Receptors, Antigen, T-Cell, gamma-delta/deficiency , Receptors, Antigen, T-Cell, gamma-delta/genetics , Th1 Cells/immunology , Th2 Cells/immunology
8.
Med Trop (Mars) ; 59(1): 79-94, 1999.
Article in French | MEDLINE | ID: mdl-10472588

ABSTRACT

Cardiac, neurologic, and gastrointestinal manifestations of Chagas Disease have been well documented, but underlying pathophysiologic mechanisms, especially of chronic myocarditis, remain unclear. In the last decades, vectorial and transfusional transmission has been diminished. However congenital forms, which were long unknown and are still poorly understood, and reactive forms, which occur in patients with acquired or induced immunodeficiency, have confounded conventional wisdom concerning the evolution of this disease. Several new diagnostic tools have been developed without replacing the traditional methods, e.g. the xenodiagnostic technique proposed by Brumpt. With regard to indirect diagnosis, further progress is needed to improve specificity and sensitivity as well as the discriminating ability of the numerous techniques now available. Recently several double-blind randomized trials showed that benznidazole may be useful for early stage disease in children under 12 years of age. Further study with long-term follow-up will be necessary to determine the value of generalizing treatment to all patients with Chagas disease regardless of age and disease stage. However the ideal trypanocidal agent has yet to be found. Although attempts to immunize animals have not been complete failures, current results are not adequate to hold forth hope of a vaccine for use in man within the foreseeable future.


Subject(s)
Chagas Disease/physiopathology , Brain Diseases/parasitology , Brain Diseases/physiopathology , Chagas Cardiomyopathy/physiopathology , Chagas Disease/congenital , Chagas Disease/diagnosis , Chagas Disease/drug therapy , Chagas Disease/transmission , Child , Child, Preschool , Diagnosis, Differential , Disease Vectors , Double-Blind Method , Follow-Up Studies , Gastrointestinal Diseases/parasitology , Gastrointestinal Diseases/physiopathology , Humans , Immunization , Immunologic Deficiency Syndromes/parasitology , Longitudinal Studies , Myocarditis/parasitology , Myocarditis/physiopathology , Nitroimidazoles/therapeutic use , Randomized Controlled Trials as Topic , Sensitivity and Specificity , Trypanocidal Agents/therapeutic use , Vaccines
10.
J Immunol ; 163(2): 875-83, 1999 Jul 15.
Article in English | MEDLINE | ID: mdl-10395682

ABSTRACT

Bruton's tyrosine kinase (Btk) mutant CBA/N mice show delayed clearance of injected microfilaria (mf) compared with wild-type CBA/J mice. Anti-mf T cells from CBA/N mice make relatively more IFN-gamma than those from CBA/J mice. The anti-mf T cell proliferative responses are also greater in CBA/N mice. This CBA/N immune phenotype is not restricted to filarial Ags, because immunization with pure proteins also yields T cell responses of greater proliferative magnitude skewed away from Th2 cytokines in CBA/N compared with CBA/J mice. The increased magnitude of CBA/N T cell proliferative responses is reflected in increases in both precursor frequencies and clonal burst sizes of responding Ag-specific T cells, and is independent of the source of re-stimulating APCs. Transfer of CBA/J peritoneal resident cells (PRCs) into CBA/N mice before pure protein immunization leads to a wild-type immune phenotype in the recipient CBA/N mice, with a reduction in the proliferative response and a relative decrease in the IFN-gamma produced. When wild-type PRC subpopulations are similarly transferred, the wild-type immune phenotype is transferred by macrophages rather than by B cells. Transfer of wild-type PRCs into CBA/N mice before injection of mf also causes similar changes in the anti-mf T cell responses and enhances the clearance of mf. Thus, Btk is involved in critical macrophage APC functions regulating priming of T cells, and can modulate these responses in pathophysiologically relevant fashion in vivo.


Subject(s)
Antigen-Presenting Cells/immunology , Immunologic Deficiency Syndromes/immunology , Macrophages, Peritoneal/immunology , Setariasis/immunology , Setariasis/parasitology , Th1 Cells/immunology , Agammaglobulinaemia Tyrosine Kinase , Animals , Antibodies, Helminth/biosynthesis , Antigen Presentation , Antigen-Presenting Cells/parasitology , Female , Immunologic Deficiency Syndromes/genetics , Immunologic Deficiency Syndromes/parasitology , Interferon-gamma/biosynthesis , Lymphocyte Activation/genetics , Macrophages, Peritoneal/parasitology , Mice , Mice, Inbred CBA , Mice, Mutant Strains , Microfilariae/growth & development , Microfilariae/immunology , Protein-Tyrosine Kinases/genetics , Serum Albumin, Bovine/immunology , Species Specificity , Th1 Cells/metabolism , Time Factors
11.
J Immunol ; 162(11): 6690-700, 1999 Jun 01.
Article in English | MEDLINE | ID: mdl-10352287

ABSTRACT

Cell-mediated immunity that results in IL-12/IFN-gamma production is essential to control infections by intracellular organisms. Studies in animal models revealed contrasting results in regard to the importance of CD40-CD40 ligand (CD40L) signaling for induction of a type 1 cytokine response against these pathogens. We demonstrate that CD40-CD40L interaction in humans is critical for generation of the IL-12/IFN-gamma immune response against Toxoplasma gondii. Infection of monocytes with T. gondii resulted in up-regulation of CD40. CD40-CD40L signaling was required for optimal T cell production of IFN-gamma in response to T. gondii. Moreover, patients with hyper IgM (HIGM) syndrome exhibited a defect in IFN-gamma secretion in response to the parasite and evidence compatible with impaired in vivo T cell priming after T. gondii infection. Not only was IL-12 production in response to T. gondii dependent on CD40-CD40L signaling, but also, patients with HIGM syndrome exhibited deficient in vitro secretion of this cytokine in response to the parasite. Finally, in vitro incubation with agonistic soluble CD40L trimer enhanced T. gondii-triggered production of IFN-gamma and, through induction of IL-12 secretion, corrected the defect in IFN-gamma production observed in HIGM patients. Our results are likely to explain the susceptibility of patients with HIGM syndrome to infections by opportunistic pathogens.


Subject(s)
CD40 Antigens/metabolism , Hypergammaglobulinemia/immunology , Immunoglobulin M/biosynthesis , Immunologic Deficiency Syndromes/immunology , Membrane Glycoproteins/blood , Th1 Cells/immunology , Toxoplasma/immunology , Adjuvants, Immunologic/physiology , Animals , Antibodies, Monoclonal/pharmacology , Antibodies, Protozoan/blood , CD40 Antigens/biosynthesis , CD40 Antigens/immunology , CD40 Ligand , Cells, Cultured , Chronic Disease , Humans , Hypergammaglobulinemia/parasitology , Immunity, Cellular , Immunologic Deficiency Syndromes/parasitology , Interferon-gamma/antagonists & inhibitors , Interferon-gamma/biosynthesis , Interleukin-12/biosynthesis , Interleukin-12/metabolism , Ligands , Lymphocyte Activation , Membrane Glycoproteins/agonists , Membrane Glycoproteins/immunology , Monocytes/immunology , Monocytes/metabolism , Signal Transduction/immunology , Th1 Cells/metabolism , Th1 Cells/parasitology , Toxoplasmosis/blood , Toxoplasmosis/immunology , Up-Regulation/immunology
12.
J Infect Dis ; 173(4): 1041-3, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8603949

ABSTRACT

To establish models for studying recurrence of visceral leishmaniasis, a growing problem in T cell-deficient patients, two approaches were investigated: treatment of euthymic BALB/c mice with quiescent Leishmania donovani infection with T cell-depleting or anti-cytokine antibodies and serial observation of acutely infected nude BALB/c mice after an initial antileishmanial response induced by amphotericin B treatment. In chronically infected euthymic mice, maintenance of acquired immunity and prevention of relapse required CD4 cells and a multicytokine-dependent mechanism involving endogenous interleukin-2, interferon-gamma, and tumor necrosis factor-alpha. Acutely infected nude mice responded to amphotericin B with a > or = 85% reduction in liver parasite burdens; however, after a brief lag, visceral infection readily recurred in the posttreatment period. Both models may be useful for testing experimental interventions designed to reduce relapse of previously controlled visceral leishmaniasis in T cell-deficient hosts.


Subject(s)
Leishmania donovani/pathogenicity , Leishmaniasis, Visceral/immunology , Animals , Chronic Disease , Disease Models, Animal , Immunologic Deficiency Syndromes/parasitology , Lymphocyte Depletion , Mice , Mice, Inbred BALB C , Mice, Nude , T-Lymphocytes/immunology , Time Factors
13.
Pediatr Infect Dis J ; 14(12): 1042-7, 1995 Dec.
Article in English | MEDLINE | ID: mdl-8745015

ABSTRACT

Little information is available on asymptomatic carriage of Cryptosporidium in immunocompetent and immunodeficient children. We prospectively studied a group of asymptomatic children, 78 immunocompetent and 50 immunodeficient, to document the incidence of asymptomatic carriage of cryptosporidiosis in such a population. We also investigated whether the treatment of children who carried asymptomatic cryptosporidiosis could help in reducing their risk of gastrointestinal symptoms as well as the shedding of infectious oocysts. The occurrence of multiple infections with common intestinal pathogens including Giardia lamblia was also investigated. Asymptomatic cryptosporidiosis was documented in 6.4% of immunocompetent and 22% of immunodeficient children. In a control symptomatic population Cryptosporidium was found in 4.4% of immunocompetent and 4.8% of immunodeficient children. Asymptomatic carriage of Cryptosporidium was documented in 2 human immunodeficiency virus-infected children, one of whom also carried Giardia asymptomatically. Treatment with spiramycin (100 mg/kg daily for 14 days) reduced significantly the duration of the shedding of potentially infectious oocysts. Finally no gastrointestinal symptoms developed in children treated for asymptomatic infection with Cryptosporidium, whereas children who were not treated developed gastrointestinal symptoms.


Subject(s)
Carrier State/parasitology , Cryptosporidiosis/etiology , Cryptosporidium/isolation & purification , Feces/parasitology , Giardia lamblia/isolation & purification , Immunocompetence , Immunologic Deficiency Syndromes/parasitology , Adolescent , Animals , Anti-Bacterial Agents/therapeutic use , Carrier State/drug therapy , Child , Child, Preschool , Cryptosporidiosis/drug therapy , Humans , Immunologic Deficiency Syndromes/drug therapy , Infant , Prospective Studies , Spiramycin/therapeutic use
14.
Radiol Med ; 87(5 Suppl 2): 13-25, 1994 May.
Article in Italian | MEDLINE | ID: mdl-8209022

ABSTRACT

Just like the lung, the brain and the spinal cord are target organs for opportunistic infections and tumors in immunocompromised patients. HIV infections and AIDS-related conditions represent the most common cause of immunodeficiency: other causes are hemoproliferative disorders and organ transplantation, but especially long-term drug and radiation therapies. Neurologic (focal, diffuse, meningeal or spinal) signs are the results of CNS infections and/or tumors or of treatment complications. Neuroimaging techniques (MRI better than CT) allow the infective or neoplastic causes of neurologic complications to be nearly always recognized and are therefore major tools for diagnosis and treatment. Lesions characterization is more difficult, since CT and MR patterns are definitely more affected by the evolutive phases of the lesions (encephalitis, cerebritis, abscess) and by their sites than by specific infective agents. However, the knowledge of the statistical possibility of brain and spine infections according to the type of immunocompromission is useful in many cases.


Subject(s)
Central Nervous System Diseases/diagnostic imaging , HIV Infections/complications , Immunocompromised Host , Immunologic Deficiency Syndromes/diagnostic imaging , Central Nervous System Diseases/microbiology , Central Nervous System Diseases/parasitology , HIV Infections/diagnostic imaging , Humans , Immunologic Deficiency Syndromes/microbiology , Immunologic Deficiency Syndromes/parasitology , Tomography, X-Ray Computed
15.
Antimicrob Agents Chemother ; 38(4): 865-7, 1994 Apr.
Article in English | MEDLINE | ID: mdl-8031061

ABSTRACT

Lasalocid, sinefungin, and dehydroepiandrosterone were tested for anticryptosporidial activity with an immunodeficient mouse model at doses that have been reported effective when tested with immunosuppressed rodent models. Small but significant reductions in oocyst excretion were only observed under some conditions with lasalocid and dehydroepiandrosterone, but sinefungin had no effect.


Subject(s)
Coccidiostats/therapeutic use , Cryptosporidiosis/drug therapy , Cryptosporidium parvum/drug effects , Immunologic Deficiency Syndromes/parasitology , Adenosine/analogs & derivatives , Adenosine/therapeutic use , Animals , Antiprotozoal Agents/therapeutic use , Cryptosporidiosis/parasitology , Dehydroepiandrosterone/therapeutic use , Lasalocid/therapeutic use , Male , Mice , Mice, Nude , Splenectomy
17.
Nature ; 356(6367): 338-40, 1992 Mar 26.
Article in English | MEDLINE | ID: mdl-1549177

ABSTRACT

The beta 2-microglobulin (beta 2m) protein associates with the products of the class I major histocompatibility (MHC) loci; this combination functions in the thymic development of and antigen presentation to CD8+ T cells. Mice in which the beta 2m gene has been disrupted by homologous recombination fail to express class I MHC gene products, and therefore lack CD8+ T cells and measurable cytotoxic T-cell responses. However, beta 2m- mice appear to have normal development of both CD4+ alpha/beta T-cell receptor (TCR+) and gamma/delta TCR+ T cells and are not overtly more susceptible than beta 2m+ mice to potential environmental agents of infection or to experimental viral infection. Here we show that beta 2m- mice suffer high parasitaemias and early death when infected with the obligate cytoplasmic protozoan parasite Trypanosoma cruzi. Despite this increased susceptibility, the beta 2m- mice are more responsive than their beta 2m+ littermates in terms of lymphokine production, making higher levels of both interleukin-2 and interferon-gamma in response to mitogen stimulation. In addition, the beta 2m- mice show essentially no inflammatory response in parasite-infected tissues. These results confirm previous experiments on mice depleted of CD8+ cells using antibody treatment in demonstrating the importance of CD8+ T cells in immune protection in T. cruzi infection. They also implicate CD8+ T cells and/or class I MHC molecules in regulation of lymphokine production and recruitment of inflammatory cells.


Subject(s)
Chagas Disease/immunology , Immunologic Deficiency Syndromes/parasitology , T-Lymphocyte Subsets/immunology , beta 2-Microglobulin/deficiency , Acute Disease , Animals , CD8 Antigens/analysis , Chronic Disease , Heart/parasitology , Interferon-gamma/biosynthesis , Interleukin-2/biosynthesis , Muscles/parasitology , Muscles/pathology , Myocardium/pathology , Time Factors , Trypanosoma cruzi/immunology
18.
Int Immunol ; 3(5): 427-33, 1991 May.
Article in English | MEDLINE | ID: mdl-1911532

ABSTRACT

Infection of several mouse strains with Trypanosoma cruzi stimulates high levels of T and B lymphocyte activities which persist during the chronic phase and is followed by specific immunosuppression and severe autoimmune pathology. Infected BALB.Xid mice carrying an X-linked mutation and lacking CD5 B cells, display poor B cell responses to T. cruzi infection, accompanied by low levels of specific and non-specific immunoglobulins in the serum. However, these animals control parasitemia, do not show the wasting observed in BALB/c mice, and develop almost no pathology early in the chronic phase. The infection of (BALB.Xid female x BALB/c male) F1 animals shows that immunodefective males behave like Xid animals in contrast to females which respond as normal BALB/c mice. These results indicate that the Xid locus controls lymphocyte responses, parasite clearance and pathology in experimental Chagas' disease.


Subject(s)
Chagas Disease/immunology , Immunologic Deficiency Syndromes/parasitology , Mice, Mutant Strains/parasitology , Trypanosoma cruzi/isolation & purification , Animals , Antibodies, Protozoan/biosynthesis , Autoimmune Diseases/genetics , Autoimmune Diseases/immunology , B-Lymphocytes/immunology , B-Lymphocytes/pathology , Chagas Cardiomyopathy/immunology , Chagas Disease/complications , Chagas Disease/genetics , Chronic Disease , Female , Immunity, Innate/genetics , Immunity, Innate/immunology , Immunologic Deficiency Syndromes/complications , Immunologic Deficiency Syndromes/genetics , Lymphocyte Activation , Male , Mice , Mice, Inbred BALB C , Mice, Mutant Strains/genetics , Mice, Mutant Strains/immunology , Trypanosoma cruzi/immunology
19.
Parassitologia ; 32(2): 275-81, 1990 Aug.
Article in English | MEDLINE | ID: mdl-2132438

ABSTRACT

In sera of 35 dogs with generalised leishmaniasis elevated levels of circulating immune complexes were detected by the 125I-C1q binding test. Furthermore, anti-heart muscle and anti-smooth muscle antibodies were detected by an indirect immunofluorescence technique in sera of infected dogs.


Subject(s)
Antigen-Antibody Complex/blood , Autoantibodies/blood , Dog Diseases/immunology , Leishmaniasis, Visceral/veterinary , Animals , Autoimmune Diseases/immunology , Autoimmune Diseases/parasitology , Autoimmune Diseases/veterinary , Dogs/immunology , Female , Immunologic Deficiency Syndromes/immunology , Immunologic Deficiency Syndromes/parasitology , Immunologic Deficiency Syndromes/veterinary , Leishmaniasis, Visceral/complications , Leishmaniasis, Visceral/immunology , Male , Phagocytosis
20.
Arch Roum Pathol Exp Microbiol ; 48(4): 357-65, 1989.
Article in English | MEDLINE | ID: mdl-2485207

ABSTRACT

By using the elective diagnosis methodology for Cryptosporidium (modified Ziehl-Neelsen and Heine stainings), 481 faeces samples from patients--children and adults--presenting acute or prolonged gastroenteritis and also from asymptomatic ones, but with professional, immunological or pharmacological risk for infection, were studied. Twelve Cryptosporidium positive cases were identified, meaning a general prevalence of 2.48% Cryptosporidium infection was detected in all investigated epidemiological groups: children, animal handlers, immunodeficient patients, immunocompetent adults with acute gastroenteritis. The risk factors hierarchy elicited the role of children collectivities attending, for acquiring the parasite in infantile cryptosporidiosis, while the opportunistic and zoonotic feature of the disease was especially present in adults' cryptosporidiosis. The assessment of cryptosporidiosis evolution, according to patients' immune status, has not allowed an obvious clinical discrepancy, since the immunocompetent subjects with professional risk had presented a prolonged oocysts excretion. The different clinico-epidemiological and parasitological features of Cryptosporidium infection are commented and the importance of applying Cryptosporidium methodology in current diagnosis practice is emphasized.


Subject(s)
Cryptosporidiosis/parasitology , Adult , Animals , Child , Cryptosporidiosis/epidemiology , Cryptosporidiosis/immunology , Cryptosporidium/isolation & purification , Feces/parasitology , Humans , Immunocompetence/immunology , Immunologic Deficiency Syndromes/epidemiology , Immunologic Deficiency Syndromes/immunology , Immunologic Deficiency Syndromes/parasitology , Prevalence , Risk Factors , Romania/epidemiology , Staining and Labeling/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...